Healthcare provider profile · identity verified

Peter E Logerfo, MD, PLLC

Family Practice · PUYALLUP, WA · NPI 1902801889

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	366	103
Amlodipine Besylate	Amlodipine Besylate	273	70
Levothyroxine Sodium	Levothyroxine Sodium	257	56
Rosuvastatin Calcium	Rosuvastatin Calcium	222	56
Metformin Hcl	Metformin Hcl	183	46
Omeprazole	Omeprazole	176	50
Gabapentin	Gabapentin	169	47
Losartan Potassium	Losartan Potassium	169	48
Metoprolol Succinate	Metoprolol Succinate	166	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	26
Tamsulosin Hcl	Tamsulosin Hcl	147	38
Lisinopril	Lisinopril	139	41
Pantoprazole Sodium	Pantoprazole Sodium	133	35
Pravastatin Sodium	Pravastatin Sodium	131	34
Hydrochlorothiazide	Hydrochlorothiazide	117	31
Mounjaro	Tirzepatide	105	17
Simvastatin	Simvastatin	105	27
Albuterol Sulfate Hfa	Albuterol Sulfate	95	38
Potassium Chloride	Potassium Chloride	93	25
Duloxetine Hcl	Duloxetine Hcl	88	25
Oxycodone Hcl	Oxycodone Hcl	85	17
Finasteride	Finasteride	82	17
Trazodone Hcl	Trazodone Hcl	77	23
Alprazolam	Alprazolam	76	17
Fluoxetine Hcl	Fluoxetine Hcl	76	14
Tizanidine Hcl	Tizanidine Hcl	74	19
Carvedilol	Carvedilol	73	18
Metformin Hcl Er	Metformin Hcl	73	22
Olmesartan Medoxomil	Olmesartan Medoxomil	72	15
Ozempic	Semaglutide	72	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	18
Allopurinol	Allopurinol	68	20
Eliquis	Apixaban	67	17
Xarelto	Rivaroxaban	66	13
Torsemide	Torsemide	65	18
Tramadol Hcl	Tramadol Hcl	63	11
Trulicity	Dulaglutide	61	suppressed
Prednisone	Prednisone	60	32
Escitalopram Oxalate	Escitalopram Oxalate	58	17
Glipizide Er	Glipizide	53	13
Bupropion Xl	Bupropion Hcl	51	15
Spironolactone	Spironolactone	51	12
Clonazepam	Clonazepam	49	suppressed
Famotidine	Famotidine	48	suppressed
Olanzapine	Olanzapine	48	suppressed
Alendronate Sodium	Alendronate Sodium	46	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	13
Citalopram Hbr	Citalopram Hydrobromide	43	12
Lorazepam	Lorazepam	41	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	18
Furosemide	Furosemide	39	12
Methocarbamol	Methocarbamol	36	15
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	12
Ondansetron Odt	Ondansetron	34	16
Jardiance	Empagliflozin	33	suppressed
Primidone	Primidone	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	13
Cephalexin	Cephalexin	28	22
Lovastatin	Lovastatin	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Valsartan	Valsartan	23	suppressed
Azithromycin	Azithromycin	22	17
Fenofibrate	Fenofibrate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Buspirone Hcl	Buspirone Hcl	21	suppressed
Cefdinir	Cefdinir	21	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Atenolol	Atenolol	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Glipizide	Glipizide	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Diazepam	Diazepam	18	suppressed
Ketoconazole	Ketoconazole	18	11
Pregabalin	Pregabalin	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fluconazole	Fluconazole	16	11
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Baclofen	Baclofen	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Mupirocin	Mupirocin	15	12
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Temazepam	Temazepam	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error